Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-24

FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approves a supplemental application for Naftin (naftifine hydrochloride) by Legacy Pharma USA Inc., resulting in labeling updates through a supplemental NDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAFTIN (NAFTIFINE HYDROCHLORIDE)

Snippet

SUPPL AP for NAFTIN (NAFTIFINE HYDROCHLORIDE)